Bortlieva 2 mg Injection 1's Substitute
›
Aureate Healthcare
₹1261
(₹1134.9 per unit)
Hetero Drugs Ltd
₹1976
(₹1778.4 per unit)
Panacea Biotec Ltd
₹1979.5
(₹1781.6 per unit)
Alkem Laboratories Ltd
₹2202.26
(₹1982.03 per unit)
Emcure Pharmaceuticals Ltd
₹2281
(₹2052.9 per unit)
Natco Pharma Ltd
₹2613.5
(₹2143.1 per unit)
Shilpa Medicare Ltd
₹2400
(₹2160.0 per unit)
Dr Reddy's Laboratories Ltd
₹2631
(₹2367.9 per unit)
Cadila Laboratories Ltd
₹3086.5
(₹2530.9 per unit)
Aureate Pharma
₹3506
(₹2874.9 per unit)
Intas Pharmaceuticals Ltd
₹3649.5
(₹2992.6 per unit)
Adley Pharmaceuticals Ltd
₹3701
(₹3034.8 per unit)
Therdose Pharma Pvt Ltd
₹4923.5
(₹4332.7 per unit)
Glenmark Pharmaceuticals Ltd
₹5365.5
(₹4399.7 per unit)
Admac Lifesciences(Oncology)
₹5891
(₹5596.45 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Bortlieva 2 mg Injection 1's to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - BORTEZOMIB-2MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Bortlieva 2 mg Injection 1's contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells. Bortlieva 2 mg Injection 1's is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in 18 years or older patients. It can be used alone or together with other medicines.
The substitutes of Bortlieva 2 mg Injection 1's contain the same active salt(s) - BORTEZOMIB-2MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Bortlieva 2 mg Injection 1's is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Bortlieva 2 mg Injection 1's are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Bortlieva 2 mg Injection 1's meet the same safety and efficacy standards as Bortlieva 2 mg Injection 1's, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Bortlieva 2 mg Injection 1's may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Bortlieva 2 mg Injection 1's if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Bortlieva 2 mg Injection 1's for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Bortlieva 2 mg Injection 1's is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Bortlieva 2 mg Injection 1's to its substitute. Always consult your doctor before switching.
Bortlieva 2 mg Injection 1's contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells.
Bortlieva 2 mg Injection 1's is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously, or SC). Bortlieva 2 mg Injection 1's must not be administered into your spinal fluid (intrathecally).
Yes, Bortlieva 2 mg Injection 1's can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.
Avoid taking Bortlieva 2 mg Injection 1's if you are pregnant because Bortlieva 2 mg Injection 1's can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of Bortlieva 2 mg Injection 1's.
Before you receive treatment with Bortlieva 2 mg Injection 1's, tell your doctor about all of your medical conditions. You should not receive Bortlieva 2 mg Injection 1's if you are allergic to bortezomib or any contents in Bortlieva 2 mg Injection 1's.
If not given an inappropriate dose, Bortlieva 2 mg Injection 1's can cause toxic effects, although not everyone gets it. So, Bortlieva 2 mg Injection 1's is prescribed by a doctor experienced in using medications to treat cancer only.